Aidite Qinhuangdao Technology Co Ltd
Aidite Qinhuangdao Technology Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to its customers.
Business. Aidite Qinhuangdao Technology Co Ltd (301580.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aidite Qinhuangdao Technology Co Ltd (301580.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Aidite Qinhuangdao Technology Co Ltd maintains a strong liquidity position, with a current ratio of 8.14, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt metric suggests a healthy cash flow position, supported by an operating cash flow of 273,658,550 CNY and a free cash flow of 118,321,270 CNY. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag.
In terms of profitability, the company's return on equity (ROE) of 9.18% and return on assets (ROA) of 7.97% are strong indicators of efficient capital use and asset management. These figures are well above the industry median for medical equipment and supplies, suggesting that the company is outperforming its peers in generating returns.
The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed. The financial data does not provide a breakdown of revenue by geographic region, but the company's operations are likely centered in China, given its listing on the Shenzhen Stock Exchange.
Looking at the growth trajectory, the company's capital expenditures were negative at -68,781,360 CNY, indicating a reduction in capital spending. This could suggest a strategic shift or a focus on optimizing existing assets rather than expanding. The outlook for the current fiscal year is stable, with no significant revenue growth expected in the near term.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is very low at 0.01, suggesting minimal leverage and a strong equity position. However, the negative net cash position after subtracting total debt is a concern and could affect the company's ability to meet short-term obligations.
Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's financial statements show consistent performance, with no significant one-time events or extraordinary items affecting the results.
- Aidite Qinhuangdao Technology Co Ltd has a strong liquidity position with a current ratio of 8.14.
- The company's ROE of 9.18% and ROA of 7.97% indicate efficient capital and asset utilization.
- The company's capital expenditures were negative, suggesting a focus on asset optimization rather than expansion.
- The company has a low debt-to-equity ratio of 0.01, indicating minimal leverage.
- The company's negative net cash position after subtracting total debt is a liquidity concern.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Aidite Qinhuangdao Technology Co Ltd Market data — financials · 2026-05-26